ArticleJournal of cardiovascular and thoracic research2019

Renin-angiotensin system blockade after transcatheter aortic valve replacement (TAVR) improves intermediate survival.

Brent KlinkhammerPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.